Integrated Cell Cycle Dysregulation Analysis Services in Cancer Progression
Creative Biolabs provides a "bench-to-informatics" solution, transforming raw omics data into therapeutic strategies. We pinpoint vulnerabilities in the mitotic checkpoint, mapping nodes like the CDK1/CCNB1 complex and APC-CDC20 machinery. Our analysis identifies high-precision signatures, such as the CDKN2A-CTSV-FOXM1 trio, offering near 100% specificity for tumor grading. This evidence-based approach supports target identification and companion diagnostic development, delivering the high-confidence data necessary for successful clinical lead generation.
Background Featured Services What We Can Offer Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
The Biological Mandate: Why Cell Cycle Regulation Matters
The hallmarks of cancer are rooted in the subversion of the cell cycle, G1, S, G2, and M phases, governed by CDK-cyclin oscillations. In aggressive malignancies, the CDK1/CCNB1 complex is often overexpressed, hijacking the G2/M checkpoint and forcing premature mitosis. In bladder carcinomas, this staged progression involves the coordinated upregulation of the spindle assembly checkpoint (SAC) and the anaphase-promoting complex/cyclosome (APC/C). This "molecular switch" facilitates chromosome segregation errors and genomic instability, establishing cell cycle profiling as a vital tool for prognostic stratification and identifying vulnerabilities in a tumor's molecular engine.
Integrated Precision Engineering Solutions
Creative Biolabs provides comprehensive genomic alteration assessment services targeting cell cycle dysregulation. We utilize NGS and multi-omics to pinpoint vulnerabilities in CDK/cyclin complexes and checkpoints, delivering actionable insights for precision oncology.
Creative Biolabs offers expert pharmacological validation for cell cycle checkpoints. We provide comprehensive in vitro and in vivo assays to verify target modulation and therapeutic efficacy, ensuring your lead candidates successfully restore genomic stability.
Creative Biolabs offers integrative cell cycle services, utilizing high-resolution flow cytometry and multi-omics to profile CDK/cyclin dynamics. We deliver actionable insights into checkpoint vulnerabilities, accelerating your drug discovery and oncology research.
Comprehensive Offerings for Cell Cycle Dysregulation Research
To support the diverse needs of the biopharmaceutical industry, Creative Biolabs offers a modular suite of services that can be tailored to specific tumor types or drug development stages. Our offerings include:
Custom Bioinformatics Pipelines
We provide end-to-end processing of RNA-seq and proteomics data to identify stage-specific cell cycle dysregulation, enabling researchers to visualize the precise molecular transitions from healthy tissue to malignant states efficiently.
Hub Gene Discovery & Ranking
Utilizing advanced network topology analysis, we rank the most promising therapeutic targets from thousands of candidates. Our algorithms prioritize high-centrality nodes, ensuring your resources focus on biologically essential driver genes.
Transcriptional Co-activator Profiling
Our platform specializes in analyzing proteins like CREPT that drive oncogenic cyclin transcription. This unique approach allows for the exploration of "undruggable" transcription factors and provides novel avenues for therapeutic intervention.
Prognostic Signature Development
We construct multi-gene risk models rigorously validated through ROC and KM survival analysis. These signatures predict disease progression and treatment response, offering critical prognostic tools for clinical stratification and patient monitoring.
Checkpoint & Spindle Assembly Analysis
Our team provides detailed mapping of dysfunctions in the mitotic spindle checkpoint and APC/C complex interactions. We pinpoint vulnerabilities in chromosomal stability that can be exploited for targeted oncology drug development.
Drug Synergy & Sensitivity Screening
By computationally correlating targets with established sensitivity databases, we identify effective combination therapies. This service helps researchers overcome chemoresistance and maximize the therapeutic impact of novel candidates in complex oncology pipelines.
Unlock the Potential of Your Oncology Data — Request a Specialist Consultation to Identify Your Next Research Candidate
Workflow
Creative Biolabs utilizes a structured, evidence-based workflow that bridges the gap between raw biological samples and research insights.
Publication
This review provides a systematic overview of fundamental methods for analyzing the mammalian cell cycle. It details techniques such as DNA content measurement, incorporation of nucleoside analogs, and kinetic approaches like time-lapse microscopy to determine phase durations and cell population dynamics. Focusing on asynchronous cultures, the article evaluates the effectiveness, reproducibility, and limitations of each method, offering essential guidance for researchers studying proliferation in contexts like cancer biology and drug development.
Fig.1 Schematic diagram of the cell cycle.1
Why Choose Us?
Creative Biolabs stands at the forefront of cell cycle research with over 20 years of specialized experience. Our unique advantage lies in our ability to integrate transcriptional co-activator analysis with downstream mitotic machinery. While standard analyses might miss "undruggable" co-factors, our platform excels at identifying these hidden nodes that serve as co-activators for RNA polymerase II, driving oncogenic transcription. Our expertise is supported by "published data" demonstrating that cell cycle dysregulation often precedes histological invasion. By identifying these "molecular switches" early, we provide our clients with a significant competitive edge in the development of first-in-class therapeutics.
Partner with the Experts — Request a Detailed Feasibility Assessment for Your Oncology Targets
FAQs
Q1: How does your service differ from standard RNA-Seq analysis?
A1: We integrate PPI networks and clinical survival data to identify "hub genes" that are biologically essential and clinically relevant, rather than providing a simple list of DEGs.
Q2: Can you help if I only have raw GEO or TCGA data?
A2: Absolutely. We specialize in mining public databases to provide context for your experimental findings or to generate new, data-backed hypotheses.
Q3: Is this service applicable to rare cancer types?
A3: Yes, our pan-cancer signatures can be adapted to rare malignancies by leveraging highly conserved cell cycle checkpoints and regulatory networks.
Customer Review
-
Exceptional Specificity
Using Creative Biolabs' cell cycle analysis in our research has significantly facilitated the stratification of high-risk NMIBC patients. Their 7-gene signature was more accurate than our previous internal models. - Dr. Al***on J
-
Target Discovery Success
The PPI network mapping provided by Creative Biolabs identified CDC20 and BUB1B as critical nodes in our lung cancer project, allowing us to pivot our lead optimization strategy toward mitotic spindle checkpoints. - Prof. Mi***el S
Related Services
Hypoxic Tumor Anaerobic Bacteria Analysis Service
Creative Biolabs provides hypoxic tumor anaerobic bacteria analysis using high-throughput platforms. We profile microbial metabolism and spatial distribution to identify targets and optimize bacteria-mediated immunotherapies.
Learn More →
NGS based Genome Sequencing Service
Creative Biolabs provides high-throughput NGS services for whole-genome analysis and tumor profiling. We deliver precise mutational data and bioinformatics to accelerate individualized cancer research and clinical genomics.
Learn More →
How to Contact Creative Biolabs
Creative Biolabs offers a world-class integrated cell cycle dysregulation analysis platform designed to identify high-value hub genes and prognostic signatures. By combining deep biological expertise with advanced computational modeling, we help you navigate the complexities of cancer progression to deliver the next generation of life-saving therapeutics.
Contact Our Team to Initiate Your Project and Secure Your Competitive Advantage
Reference
-
Ligasová, A., I. Frydrych, and K. Koberna. "Basic Methods of Cell Cycle Analysis." Int J Mol Sci 24.4 (2023). Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms24043674
For Research Use Only | Not For Clinical Use
Download our brochure